咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Research trends in pharmacogen... 收藏

Research trends in pharmacogenomics of immune diseases:A bibliometric study

作     者:Xue-Ting Mao Hong-Ting Nie Guan-Ru Chen Xiao-Ling Wang Xiao-Lin Xu 

作者机构:Department of PharmacyBeijing Children's HospitalCapital Medical UniversityNational Center for Children’s HealthBeijing 100045China. Department of Clinical PharmacologySchool of Pharmaceutical SciencesCapital Medical UniversityBeijing 100069China. Department of Clinical PharmacyAnhui Provincial Children's HospitalHefei 230000China. 

出 版 物:《Clinical Research Communications》 (临床研究通讯)

年 卷 期:2024年第7卷第3期

页      面:13-22页

学科分类:0502[文学-外国语言文学] 050201[文学-英语语言文学] 05[文学] 

基  金:the National Key Research and Development Program of China(2021YFC2702005) Beijing Hospitals Authority’s Ascent Plan(DFL20221001) R&D Program of Beijing Municipal Education Commission(KZ202210025030) Beijing Municipal Hospital Scientific Research and Cultivation Program(PX2023043) 

主  题:pharmacogenomics immunization American Science Citation Index Online Edition bibliometrics analysis CiteSpace 

摘      要:Background:Numerous academic studies have explored the utilization of pharmacogenomics in the context of immunologic diseases in recent *** this,there is a notable absence of scientometric analyses focusing on the literature within this ***:This study employs bibliometric methods to systematically categorize the literature pertaining to pharmacogenomics in the context of immune diseases,with the aim of identifying research trends,key areas of interest,and prominent research institutions in this ***:Scientometric analysis compared 812 international publications with 71 Chinese publications,finding that the prevailing international research focus is on the precise dosing and therapy of immunosuppressants like mercaptopurine,a topic more extensively explored than in Chinese ***:It is found that the research focus is centered on precision medication and therapy,with a particular emphasis on the utilization of different immunosuppressants like mercaptopurine and ***,it is anticipated that precision dosing of emerging immunosuppressants like sirolimus will be a significant are a of future research.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分